TransThera Sciences (Nanjing) (2617 HK)

Analysis

Health Care • China

TransThera Sciences (Nanjing), Inc. develops and manufactures biopharmaceutical products. The Company produces oncology, inflammatory, and cardiovascular treatment drugs. TransThera Sciences (Nanjing) serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00